Filing Details
- Accession Number:
- 0001645627-17-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-18 11:16:26
- Reporting Period:
- 2017-05-16
- Filing Date:
- 2017-05-18
- Accepted Time:
- 2017-05-18 11:16:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,787,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,788,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,789,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,790,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,791,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,792,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,793,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,794,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,795,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,796,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,797,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,798,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,799,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,800,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,801,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,802,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,803,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,804,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,805,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,806,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,807,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,808,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,809,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,810,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,811,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,812,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,813,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,814,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,815,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,816,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
